Moderna Stock Price - MRNA

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 22.50 ▲ 0.14 (0.63%)
Company Name Stock Ticker Symbol Market Type
Moderna Inc MRNA NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.38 -1.67% 22.36 23.50 21.8501 23.50 22.74 23:59:39
Bid Price Ask Price Spread Spread % News
20.01 22.85 2.84 12.43% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
28,862 5,649,269 $ 22.61 $ 127,706,014 2,536,655 11.54 - 29.79
Last Trade Time Type Quantity Stock Price Currency
19:58:48 50 $ 22.50 USD

Moderna Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 7.45B 333.25M $ -384.73M -5.00 - 310.73M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Moderna News

Loading Messages....

Latest MRNA Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MRNA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week20.7924.2420.6222.035,911,6901.577.55%
1 Month18.9624.2417.6820.803,100,8763.4017.93%
3 Months16.9424.2416.0019.942,235,1565.4232.0%
6 Months14.1724.2411.5417.742,211,4198.1957.8%
1 Year14.8429.7911.5418.191,694,9317.5250.67%
3 Years22.0029.7911.5418.051,696,3980.361.64%
5 Years22.0029.7911.5418.051,696,3980.361.64%

Moderna Description

Moderna Inc is engaged in creating transformative medicines based on messenger RNA, or mRNA. Its therapeutic and vaccine development programs span infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases. The company's approach is to use mRNA medicines to instruct a patient's own cells to produce proteins that could prevent, treat, or cure disease.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.